Results 71 to 80 of about 1,083 (145)

OBSTACLES IN MANAGING GIANT PROLACTINOMA

Journal of the ASEAN Federation of Endocrine Societies
INTRODUCTION/BACKGROUNDSarcoidosis is a multisystem granulomatous inflammatory disorder with common involvement of the lungs, lymph nodes and heart. Neurosarcoidosis, especially hypothalamicpituitary involvement, is a rare phenomenon (<10% of sarcoidosis patients).
Siti Zakiah Ahmad Daud, Syarifah Syahirah Syed Abas, Nor Afidah Karim, Yong Lit Sin, Noor Lita Adam   +4 more
openaire   +1 more source

Case report and literature review of pituitary apoplexy in a 14-year-old girl with prolactinoma

Discover Medicine
Background Pituitary adenomas are rare in pediatric populations, with prolactinomas representing 20–39% of childhood cases. Pituitary apoplexy-hemorrhage or infarction of a pituitary adenoma-occurs in only 2–12% of tumors and is exceedingly uncommon in ...
Xuewen Yuan, Jiexin Yu, Xinfa Wang, Wei Gu   +3 more
doaj   +1 more source

Klinicheskiy sluchay gigantskoy prolaktin-sekretiruyushchey adenomy gipofiza u podrostka

Ожирение и метаболизм, 2010
Резюме. Пролактиномы редко выявляются у лиц детского возраста, но зачастую характеризуются более агрессивным ростом. И, несмотря на то, что подходы к лечению этих опухолей у взрослых хорошо изучены и в настоящее время предпочтение отдается ...

doaj   +1 more source

A "giant" prolactinoma [PDF]

Journal of Neurology, Neurosurgery & Psychiatry, 1997
Reuter, Uwe, Mehraein, Susan, Arnold, Gerhard, Lehmann, Rüdiger   +3 more
openaire   +3 more sources

EHA2024 Hybrid Congress

HemaSphere, Volume 8, Issue S1, June 2024.
wiley   +1 more source

Giant Invasive Prolactinoma

Archivos de Neurociencias, 2023
Amado Jiménez Ruiz, Juan Carlos Ayala Alvarez, Margarita Riojas Barrett, Naomi Nazareth Becerra Aguiar, Rebeca Soledad Gamboa Gauna, José Luis Ruiz Sandoval   +5 more
openaire   +1 more source

Pediatric Giant Prolactinoma Presenting With Acute Obstructive Hydrocephalus and Intracranial Hypertension. [PDF]

J Endocr Soc, 2021
Hendrix G, Benjamin R, MacIver N, Barboriak DP, Fuchs H, Gumus Balikcioglu P.   +5 more
europepmc   +2 more sources

The Differences Between Dopamine Agonist-Resistant and -Non-Resistant Prolactinomas: Are There Any Predictors of a Good Response?

Biomedicines
Background/Objectives: Dopamine agonists (DAs) are the first-line therapy for prolactinomas; however, a subset of patients exhibits resistance or incomplete response. Methods: This retrospective study included 85 of 125 eligible consecutive patients with
Maria Komisarz-Calik, Anna Bogusławska, Aleksandra Gamrat-Żmuda, Mari Minasyan, Beata Piwońska-Solska, Jacek Kunicki, Grzegorz Zieliński, Agata Faron-Górecka, Alicja Hubalewska-Dydejczyk, Aleksandra Gilis-Januszewska   +9 more
doaj   +1 more source

A case of acute hydrocephalus due to a giant prolactinoma rescued by transventricular neuroendoscopic tumorectomy. [PDF]

Surg Neurol Int, 2023
Iwamura H, Nonaka M, Li Y, Ueno K, Takeda J, Hashiba T, Asai A.   +6 more
europepmc   +1 more source

Giant Prolactinoma with Pituitary Apoplexy in Pregnancy: High Fetomaternal Risk. [PDF]

J Obstet Gynaecol India, 2022
Singh S, Mohakud S.
europepmc   +1 more source